Document Detail


Hypoxanthine levels in human urine serve as a screening indicator for the plasma total cholesterol and low-density lipoprotein modulation activities of fermented red pepper paste.
MedLine Citation:
PMID:  20797477     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Fermented red pepper paste (FRPP) is one of the most well-known traditional foods in Korea. The effects of FRPP in experimental animals and adipocytes have been previously reported. However, the biochemical effects have not yet been validated in humans with various genetic backgrounds and environmental factors. In this study, 28 female volunteers (body mass index, more than 23 kg/m(2)) aged 19 to 60 years were treated with either FRPP or a placebo for 12 weeks. Marked cholesterol modulation was observed in the FRPP-treated group compared with the placebo group. Although the baseline (pretreatment) total cholesterol and low-density lipoprotein levels and body mass index of the volunteers did not differ significantly between the placebo- and FRPP-treated groups, FRPP caused a modulation of cholesterol levels not seen in the placebo group, causing either no variation or a decrease in low-density lipoprotein and total cholesterol levels. Thus, urinary metabolomic profiling of pretreatment samples was carried out in these 2 FRPP-treated groups using (1)H-nuclear magnetic resonance-based metabolomic techniques. These 2 groups, with their opposing cholesterol-modulation tendencies, could be clearly differentiated by orthogonal projections to latent structures-discriminant analysis-derived score plots. In addition, their levels of hypoxanthine differed markedly. We propose that urinary hypoxanthine levels can be used as a screening biomarker to predict the efficacy of the cholesterol-modulating activity of FRPP in human subjects.
Authors:
Yujin Kim; Youn-Je Park; Seung-Ok Yang; So-Hyun Kim; Sun-Hee Hyun; Sayeon Cho; Young-Suk Kim; Dae Young Kwon; Youn-Soo Cha; Soowan Chae; Hyung-Kyoon Choi
Related Documents :
2184657 - Beneficial effects of indapamide on lipoproteins and apoproteins in ambulatory hyperten...
2525337 - Metabolic changes during medical treatment of endometriosis: nafarelin acetate versus d...
8467107 - Long-term serum lipid lowering, behavior modification, and weight loss in obese women.
3656097 - Hypolipidemic activity of trimethylamine-carbomethoxyborane and related derivatives in ...
6877467 - Effects of zinc deficiency on lead toxicity in rats.
10518007 - Effect of ascorbic acid and green tea on endogenous formation of n-nitrosodimethylamine...
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Nutrition research (New York, N.Y.)     Volume:  30     ISSN:  1879-0739     ISO Abbreviation:  Nutr Res     Publication Date:  2010 Jul 
Date Detail:
Created Date:  2010-08-27     Completed Date:  2010-12-10     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8303331     Medline TA:  Nutr Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  455-61     Citation Subset:  IM    
Copyright Information:
Copyright 2010 Elsevier Inc. All rights reserved.
Affiliation:
College of Pharmacy and Research Center for Biomolecules and Biosystems (WCU), Chung-Ang University, Seoul, Republic of Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Biological Markers / urine*
Capsicum* / chemistry
Cholesterol / blood*
Cholesterol, LDL / blood
Female
Fermentation*
Humans
Hypoxanthine / urine*
Magnetic Resonance Spectroscopy
Metabolomics / methods
Middle Aged
Oryza sativa
Placebos
Soybeans
Chemical
Reg. No./Substance:
0/Biological Markers; 0/Cholesterol, LDL; 0/Placebos; 57-88-5/Cholesterol; 68-94-0/Hypoxanthine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Inclusion of Atlantic salmon in the Chinese diet reduces cardiovascular disease risk markers in dysl...
Next Document:  Strawberries decrease atherosclerotic markers in subjects with metabolic syndrome.